FDA Approves TAS-102

** Updated 10/6/15 with patient support information. See below! Good news! The FDA approved the use of the drug TAS-102 (brand name LONSURF® (trifluridine and tipiracil hydrochloride)) on September 22, 2015 for patients with metastatic colorectal cancer. This means there’s a new treatment option for…

Read Full Post

GI ASCO 2015 – Recap

By Keavy McAbee, patient resources Fight Colorectal Cancer’s team traveled to San Francisco Jan. 15-17 to attend the 2015 Gastrointestinal Cancers Symposium (also known as GI ASCO), an annual event for medical professionals to share the latest research of gastrointestinal cancers – which include pancreas,…

Read Full Post

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work…

Read Full Post